HomeCompaniesWith upside potential, The Chemours Company (CC) Stock is well-positioned to grow

With upside potential, The Chemours Company (CC) Stock is well-positioned to grow

UBS raised the price target for the The Chemours Company (NYSE:CC) stock from “a Neutral” to “a Buy”. The rating was released on January 24, 2023, according to finviz. We previously noted in another research note published on January 11, 2023 by BofA Securities that upgraded the stock from a Neutral to a Buy with a price target of $40 for CC stock. The research report from RBC Capital Mkts has downgraded the stock from Outperform to Sector Perform, with a price target set at $33. The stock was initiated by Credit Suisse, who disclosed in a research note on November 01, 2022, to Underperform and set the price objective to $24. In their research brief published October 13, 2022, Goldman analysts initiated the The Chemours Company stock to Neutral with a price target of $30.

The latest trade, Performances and Moving Averages give us the following Picture

The share price of The Chemours Company (NYSE:CC) raised 1.59% to close Tuesday’s market session at $34.46, higher as compared to yesterday’s close. The stock price fluctuated between $34.17 and $35.40 throughout the trading session with the volume trading being 1456375 shares, which represented a significant variation when compared to the three months average volume of 1.16 million shares. The firm’s stock price fluctuated 4.14% within the last five trades and 11.34% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 0.79% in the last 6 months and 16.77% was added to its value over the previous 3 months. CC stock is trading at a margin of 7.88%, 8.69% and 3.78% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


As of the close of trading, CC deals in the Basic Materials domain. The stock is trading -23.33 percent below its 52-week high and 52.75 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is 11.59. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does The Chemours Company’s Profitability and Valuation Ratios Tell Us About the Stock?

With regard to the profitability of the company, the operating margin is currently at 14.10 percent and the profit margin is 12.90 percent, and the company has reported a gross margin of 25.70 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.

The stock’s market cap achieved a total value of $5.03 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for The Chemours Company (NYSE:CC) is 6.14. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 8.29. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 0.72 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 4.17, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.10 percent of The Chemours Company shares are owned by insiders, and 76.70 percent are held by financial institutions. Sparks Edwin C, the President, Titan Tech Chem Sol at The Chemours Company (CC) has sold 22,142 shares of firm on Jun 07 at a price of $43.59 against the total amount of $0.97 million. In another inside trade, Ralhan Sameer, SVP, CFO of The Chemours Company (NYSE:CC) sold 20,175 shares of the firm on May 09 for a total worth of $0.81 million at a price of $40.01. An inside trade which took place on May 06, SVP, CFO of The Chemours Company Ralhan Sameer sold 35,188 shares of firm against total price of $1.41 million at the cost of $40.14 per share.



Please enter your comment!
Please enter your name here

Recent Post